Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Yuen

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Optics Express|July 16, 2021
High-flux, adjustable, compact cold-atom sourceSean Ravenhall, Benjamin Yuen, Chris Foot
JMIR Diabetes|October 20, 2025
Revolutionizing Hypoglycemia Management in Long-Term Care: Lessons Learned From a Pilot Quality Improvement Initiative Using Continuous Glucose MonitoringDenis O'Donnell, Sue Burns, Shirley Drever, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 2, 2011
Mice expressing T4826I-RYR1 are viable but exhibit sex- and genotype-dependent susceptibility to malignant hyperthermia and muscle damageBenjamin Yuen, Simona Boncompagni, Wei Feng, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Multi-omic Profiling Reveals Early Immunological Indicators for Identifying COVID-19 ProgressorsKatherine A Drake, Dimitri Talantov, Gary J Tong, et al.
Clinical Immunology (Orlando, Fla.)|October 18, 2023
Multi-omic profiling reveals early immunological indicators for identifying COVID-19 ProgressorsKatherine A Drake, Dimitri Talantov, Gary J Tong, et al.
Nature|November 10, 2022
Non-viral precision T cell receptor replacement for personalized cell therapySusan P Foy, Kyle Jacoby, Daniela A Bota, et al.
Nature|March 8, 2023
Neoantigen-targeted CD8<sup>+</sup> T cell responses with PD-1 blockade therapyCristina Puig-Saus, Barbara Sennino, Songming Peng, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Optics Express|July 16, 2021
High-flux, adjustable, compact cold-atom sourceSean Ravenhall, Benjamin Yuen, Chris Foot
JMIR Diabetes|October 20, 2025
Revolutionizing Hypoglycemia Management in Long-Term Care: Lessons Learned From a Pilot Quality Improvement Initiative Using Continuous Glucose MonitoringDenis O'Donnell, Sue Burns, Shirley Drever, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 2, 2011
Mice expressing T4826I-RYR1 are viable but exhibit sex- and genotype-dependent susceptibility to malignant hyperthermia and muscle damageBenjamin Yuen, Simona Boncompagni, Wei Feng, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Multi-omic Profiling Reveals Early Immunological Indicators for Identifying COVID-19 ProgressorsKatherine A Drake, Dimitri Talantov, Gary J Tong, et al.
Clinical Immunology (Orlando, Fla.)|October 18, 2023
Multi-omic profiling reveals early immunological indicators for identifying COVID-19 ProgressorsKatherine A Drake, Dimitri Talantov, Gary J Tong, et al.
Nature|November 10, 2022
Non-viral precision T cell receptor replacement for personalized cell therapySusan P Foy, Kyle Jacoby, Daniela A Bota, et al.
Nature|March 8, 2023
Neoantigen-targeted CD8<sup>+</sup> T cell responses with PD-1 blockade therapyCristina Puig-Saus, Barbara Sennino, Songming Peng, et al.
Pageof 1